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The association between ultraviolet radiation (UVR) exposure and both skin cancer and photo-aging is well
documented. In addition to the conventional organic-chemical and physical-mineral type sunscreens, other
non-sunscreen protective strategies have been developed. These include topically applied botanical extracts
and other antioxidants as well as topical DNA repair enzymes. Standard terms of photoprotection such as sun
protection factor (SPF) do not accurately reflect the photoprotection benefits of these materials. For example, in
spite of minimal SPF, tea extract containing polyphenols such as ()-epigallocatechin-3-gallate (EGCG) has been
shown to protect against UV-induced DNA damage and immune suppression, in part through its ability to
reduce oxidative stress and inhibit NF-kB. The addition of botanical antioxidants and vitamins C and E to a
broad-spectrum sunscreen may further decrease UV-induced damage compared with sunscreen alone. These
agents have been shown to enhance protection against UV-induced epidermal thickening, overexpression of
MMP-1and MMP-9, and depletion of CD1aþ Langerhans cells. Non-sunscreen materials such as botanical
extracts, antioxidants, and DNA repair enzymes can contribute value when applied topically to human skin
in vivo.
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INTRODUCTION
There is growing interest in the potential for ‘‘non-sunscreen’’
agents to add protection against exposure to ultraviolet
radiation (UVR). This review summarizes several salient
points about this issue, including how non-sunscreen agents
are different from sunscreens in their mechanism of action, in
the different end points important in measuring efficacy, and
in the benefits of their use. In addition, a preliminary study in
which antioxidants were added to a broad-spectrum sun-
screen with a sun protection factor (SPF) of 25 is reported.
It is important to decrease UV exposure by avoiding
excessive time in the sun, wearing protective clothing, and
using a sunscreen. It should also be noted that no sunscreen is
effective in reducing total UVR exposure under every
scenario. This would suggest that sunscreens are to be
recommended, but that there are additional topical measures
that can be taken to further reduce damage that ordinarily
would lead to photo-aging and skin cancer.
It has been suggested that augmenting sunscreens with
active natural ingredients can help increase the photoprotec-
tive qualities of sunscreens and offer greater protection to
patients, but there has been little clinical research to show: (a)
exactly what ingredients, (b) at what concentration, (c)
combined with which other materials, are beneficial to
human skin.
A cascade of reactions occurs on exposure of human skin
to sunlight, primarily owing to the ultraviolet wavelengths
(UVRs). It is well known that UVR induces an array of
damage ‘‘end points’’ in human skin, including pyrimidine
dimers, oxidative DNA damage, mtDNA damage, release of
pro-inflammatory and immunosuppressive cytokines, isomer-
ization of trans-urocanic acid to the immunosuppressive cis-
urocanic acid, and p53 mutations, in addition to the easily
observable erythema on which SPF is based. It is sensible,
therefore, that many of the non-traditional sun protection
agents be tested against these additional end points for
possible protective capabilities. Wavelengths in the UVA
portion of the spectrum (320–400 nm) have been shown to
induce oxidative stress through reactive oxygen species
(ROS), including singlet oxygen, and other non-radical and
radical ROS, such as hydrogen peroxide and the superoxide
radical. (Grether-Beck et al., 1996; Berneburg et al., 1999;
Klotz et al., 2001; Bachelor and Bowden, 2004; Halliday,
2005). This oxidative stress leads to DNA lesions such as
8-hydroxy-20deoxyguanine (8-OH-dG), which has been
proposed as a critical source of mutations, as UVA penetrates
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farther than UVB into the skin, and it may transform stem
cells (Agar et al., 2004).
In an attempt to block some of the damage caused by sun
exposure, antioxidants have been explored as a means to deal
with UVR-induced oxidative stress, and UVA radiation in
particular. Some topical and systemic antioxidants include
resveratrol, vitamin E, vitamin C, ()-epigallocatechin-3-
gallate, and retinyl palmitate (retinoids) (for reviews, see Afaq
and Mukhtar, 2006 and Wright et al., 2006). Some materials
are more accurately referred to as plant extracts (although
there is clearly an overlap with the previous category), and
they have also been reported to protect the skin against
various UVR-induced damage end points. The extracts best
supported by experimental evidence include tea extracts
(Elmets et al., 2001), lutein (Lee et al., 2004), tamarind
(Kuchel et al., 2005), certain flavonoids (Moore et al., 2006;
Lin et al., 2008), fern extract (Caccialanza et al., 2007;
Siscovick et al., 2008), pycnogenol (Sime and Reeve, 2004),
and lycopene (Stahl and Sies, 2007). Topical DNA repair
enzymes were first introduced over a decade ago as potential
therapies for UV-induced damage, specifically for those
patients who are genetically deficient in repair enzymes
(xeroderma pigmentosum) (Yarosh et al., 2001). Since then,
the variety of available repair enzymes has increased (to
include those targeting oxidative DNA lesions), along with
the increased sophistication of delivery systems and the more
widespread commercial use of this technology (Yarosh et al.,
2005; Ke et al., 2007). Recently, our group reported on the
role of topical DNA repair enzymes in preventing UV-
induced immunosuppression (Lucas et al, 2008). Topical
application of repair enzymes, although effective only after
UV exposure, may be an important new weapon in the fight
against sunlight-induced skin cancer.
RESULTS AND DISCUSSION
To test the hypothesis that non-erythema end points
indicative of UV damage could be prevented better by the
addition of antioxidants to a commercial sunscreen, a
preliminary study was performed. Five volunteers were
enrolled after written informed consent. The mean age was
25, and the range was 18–40 years. Subjects were of
Fitzpatrick skin types I-III, primarily II. The mean minimal
erythema dose (MED) was 52mJ cm2, with a range of
20–60mJ cm2. Subjects were treated with two test products:
(1) a commercially available skin moisturizer with an SPF of
25 also containing antioxidants (that is, sunscreens plus
antioxidants); and (2) the same SPF 25 moisturizer without
the antioxidants (that is, sunscreens alone).
Immune suppression has been shown to be a critical
aspect of UVR-induced non-melanoma skin carcinogenesis.
Depletion of epidermal Langerhans cells (LC), the skin’s
antigen-presenting cells, has been used as a surrogate for
immune suppression, although functional disturbances may
exist before the numbers are significantly decreased. In the
preliminary study reported here, LCs were quantified to
reflect the efficacy of the test materials in protecting against
UVR-induced immune suppression. Both sunscreens alone
(SS) and sunscreensþ antioxidants (SSþAOx) resulted in
significant protection against solar-simulated UV-induced
reduction in LC numbers in human subjects (Figure 1). The
average UV-induced reduction of LC in skin irradiated with
two times the MED was 35% compared with non-irradiated
sites. In sites pre-treated with SS alone or with SSþAOx, the
average reduction of LC was 0 and 4%, respectively. There
was no significant difference between the two treatments.
UVR has been shown to activate matrix metalloprotei-
nases (MMPs), and recent studies have determined that
MMP1 is the major enzyme implicated in collagen damage
and photo-aging of UV-irradiated human skin (Brennan et al,
2003). Therefore, this study also asked whether the addition
of antioxidants to an SPF 25 sunscreen would improve
protection against solar-simulated UVR-induced activation of
MMP1. Both sunscreens and sunscreensþ antioxidants re-
duced the expression of MMP1 relative to unprotected UV-
irradiated control skin (Figures 2 and 3). SS alone decreased
the level of MMP1 per area by 43%, whereas SSþAOx
diminished MMP1 production by 60%. The difference in
protection between the SS alone and the SSþAOx was
significant, and suggests that additional benefit against sun
damage can be gained by adding antioxidants to sunscreens.
It has been known for some time that UVA is particularly
efficient at inducing ROS and degradative dermal enzymes,
so it is logical that antioxidants might prevent this end point
in particular (Scharffetter et al, 1991). In theory, topically
applied antioxidants should reduce the damage caused by
ROS, impede or lessen tissue damage, and promote repair
after UVR. This study shows that it is possible to increase
protection from UV radiation by a broad-spectrum SPF 25
sunscreen product through the addition of selected antiox-
idant botanical ingredients. Further, as the SSþAOx for-
mulation is a commercially available product that has been
shown to be stable, safe, and efficacious, this suggests a real
developmental advance in sun protection.
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Figure 1. Effect of Sunscreen and Antioxidants on Langerhan’s cell number
(CD1aþ cells). The skin of human subjects was exposed to 2 MED of ssUVR
after pretreatment with the indicated topical agents. Langerhans cells were
enumerated as described in Materials and Methods and indicated here as the
average per high-powered field±SD. Both sunscreens alone (SS) or
sunscreensþ antioxidants (SSþAOx) protected against UV-induced
depletion. The difference between the two sunscreen formulations was not
significant.
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MATERIALS AND METHODS
All procedures were approved by the Institutional Review Board of
University Hospitals of Cleveland.
Products tested
Two formulations with an SPF of 25 were tested, one with added
antioxidants (SSþAOx) and one without (SS alone). The UV filters
were benzophenone, avobenzone, and octylmethoxycinnamate.
The antioxidants were caffeine, vitamin E, vitamin C (aminopropyl
ascorbyl phosphate), echinacea pallida extract, gorgonian extract,
and chamomile essential oil. The label SPF was determined by CPT
Laboratories (Fairfield, NJ) following FDA guidelines.
UV light source
ssUVR was delivered using a 1,000 Watt xenon arc solar simulator
model 6271 (Oriel Instruments, Stratford, CT), with a dichroic mirror
and 81017bis filter (WG320 per 1.5mm), producing a spectrum of
290–400nm. Irradiance was measured using an IL1700 radiometer
(International Light, Newburyport, MA) equipped with a sensor for
UVA (SED 033, UVA filter no. 19672) and UVB (SED 240, UVB filter
no. 15541) positioned 10 inches from the light source.
Protocol
A schematic summary of the study protocol is provided (Figure 4).
Individual baseline MED and SPF determinations were performed
(days 0, 1). On day 2, each of the two test products (SS and
SSþAOx) was applied on separate areas on the buttock at a dose of
2mg cm2. Fifteen minutes later, simulated solar radiation (ssUVR)
was delivered on these sites as well as on a third site that was not
pre-treated with any product. For the product-treated sites, the dose
of UV delivered was calculated as 2MED multiplied by the SPF of
the product, to account for the UV filtration provided by the
sunscreens. Each site measured 2.5 2.5 cm. A fourth site was
marked but not exposed to UV to serve as control. Two days after
irradiation (day 4), skin punch biopsies were obtained from the four
skin sites mentioned above.
Tissue analysis
Immunohistochemical staining for CD1aþ cells (LC) and MMP1
was performed on frozen sections from the punch biopsies. Acetone-
fixed 4–6 mm cryostat sections were stained using a Vectastain Elite
ABC reagent kit that contained blocking serum (Mouse IgG, PK-
6102), biotinylated secondary antibody, and Avidin DH/biotinylated
HRP (Vector Labs, Burlingame, CA). Samples were incubated with a
purified mouse anti-human CD1A monoclonal antibody 1:500
dilution (Immunotech, Cat. No. 1590, Emeryville, CA). Mouse
IgG2a kappa, M-7769 was used as isotype control (Sigma-Aldrich
Inc., St Louis, MO). For MMP1 detection, samples were incubated in
mouse anti-MMP1 monoclonal antibody or mouse IgG1 isotype
control overnight (R&D Systems Inc., Minneapolis, MN: diluted
1:250 in 3% normal horse serum in PBS). Peroxidase localization
was performed using DAB (Cat. no. SK-4100, Vector Labs,
Burlingame, CA), and counterstaining was applied using methyl
0
2
4
6
8
10
12
R
el
at
iv
e 
M
M
P1
 s
ta
in
in
g
(%
 ar
ea
)
2 MED vs 2 MED + SS, P < 0.002
2 MED vs 2 MED + SS + AOx, P < 0.0001
2 MED + SS vs 2 MED + SS + AOx, P < 0.05
 2 MED +
SS+Aox
No
ssUVR 2 MED
2 MED
+ SS
Figure 2. The effect of ssUVR, sunscreens, and sunscreens plus antioxidants
on MMP1 expression in human skin in vivo. The skin of human subjects was
treated as indicated: (a) no ssUVR, (b) 2 MED ssUVR, (c) 2 MED plus
SSþAOx, and (d) 2 MEDþ SS alone. Biopsies were analyzed by
immunohistochemistry using a monoclonal antibody to MMP1 and processed
according to the manufacturer’s suggestion (R & D Systems Inc., Minneapolis,
MN, USA). Measurements were obtained for 8–20 areas within each tissue
section, and the averages calculated. Average values±SEM are shown after
analysis using Image-Pro Plus (Media Cybernetics Inc., San Diego, CA).
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Figure 3. A representative image of immunohistochemical analysis of MMP1
expression in human skin in vivo. The skin of human subjects was treated as
indicated: (a) no ssUVR, (b) 2 MED ssUVR, (c) 2 MED plus SSþAOx, and (d)
2 MEDþ SS alone. Biopsies were analyzed for the presence of MMP1 and
processed according to the manufacturer’s suggestion (R & D Systems Inc.).
Hematoxylin is shown as blue–purple and MMP1 as brown.
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Figure 4. Diagram illustrating the experimental protocol followed for the
clinical aspects of the study. On day 0, a standard MED determination was
initiated and erythema was used to determine the subject’s MED 24hours
later. On day 1, products were applied at 2mg cm2 over two 68 cm areas.
The material was left to dry for 15minutes, and then the sites were irradiated
for determination of product SPF. On day 2 after SPF was determined,
products were applied on different sites, and both product and no-treatment
control sites were irradiated with 2 MED. Day 3 consisted of chromameter
readings of three sites. On day 4, four 6mm punch biopsies were taken, one
from each of the four sites.
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green. The number of CD1aþ cells in the epidermis and the
percentage of MMP1þ (brown)-stained areas in the epidermis and
dermis per high-powered field were calculated using Image-Pro Plus
(Media Cybernetics Inc., San Diego, CA). Data were compared
between control and UV-irradiated skin, as well as product-treated
skin samples using standard t-testing. A P-value of o0.05 was
considered significant.
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